USR Reus-Tarragona

RESPONSABLE
avatar_investigadors.jpg
Enric Aragonès Benaiges
earagones.tgn.ics@gencat.cat
Reus-Tgn - USR equip

Publicacions

IMPLEMENTATION OF AN INTERVENTION TO IMPROVE INITIAL MEDICATION ADHERENCE IN PRIMARY CARE: PROCESS EVALUATION WITH MIXED METHODS (IMA-CRCT)

C. CORRAL-PARTEARROYO, A. SÁNCHEZ-VIÑAS, M. PEÑARRUBIA-MARÍA, M. GIL-GIRBAU, I. AZNAR-LOU, C. GALLARDO-GONZÁLEZ, M. OLMOS-PALENZUELA and M. RUBIO-VALERA
Gaceta Sanitaria. 2025 Sep 1;

REASONS LEADING TO CHRONIC BENZODIAZEPINE USE: A QUALITATIVE PERSPECTIVE

M. PEÑARRUBIA-MARÍA, M. OLMOS-PALENZUELA, L. PARKER, I. AZNAR-LOU, M. RUBIO-VALERA and M. GIL-GIRBAU
Gaceta Sanitaria. 2025 Sep 1;

FEATURE OF A COST-EFFECTIVENESS STUDY OF TELEPHONE MONITORING IN HEART FAILURE USING ARTIFICIAL INTELLIGENCE WITH NATURAL LANGUAGE PROCESSING: PILOT STUDY

M. RUBIO-VALERA, C. CORRAL-PARTEARROYO, A. OLIVELLA, I. AZNAR-LOU, E. GIMÉNEZ-GARCÍA, A. ORTEGA and I. FERREIRA-GONZÁLEZ
Gaceta Sanitaria. 2025 Sep 1;

EFFECTIVENESS AND COST-EFFECTIVENESS OF A SHARED DECISION-MAKING INTERVENTION IN PRIMARY CARE: A REAL-LIFE DATA-BASED CLINICAL TRIAL IMA-CRCT

C. CORRAL-PARTEARROYO, A. SÁNCHEZ-VIÑAS, M. PEÑARRUBIA-MARÍA, M. GIL-GIRBAU, I. AZNAR-LOU, C. GALLARDO-GONZÁLEZ, C. OLMOS-PALENZUELA and M. RUBIO-VALERA
Gaceta Sanitaria. 2025 Sep 1;

Evaluating the Safety Profile of the Janssen COVID-19 Vaccine (JCOVDEN): A VAC4EU Post-Authorization Safety Study

F. AHMADIZAR, A. ROYO, O. RYAN, E. PLANA, J. ARNAU, A. TARAZJANI, S. MOHAMMADI, R. GARCIA-ESTEBAN, R. PAJOUHESHNIA, K. BORIC, E. PALÁ, A. BRUTAU, M. HAUGH, J. MARTÍNEZ, A. URCHUEGUÍA, E. MARTÍNEZ, M. HERRERO-SILVESTRE, T. LYSEN, J. OVERBEEK, J. GASPERSZ, F. VILLALOBOS, C. BISSACCO, C. WILLIAMS, N. PRAET, M. STURKENBOOM and J. FORTUNY
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2025 Aug 1;

Patronat

Col·laboradors

Acreditacions